Cargando…

1355. Resistance in Gram-Negative Bacteria in the Pediatric Patient Population by Age and Sex

BACKGROUND: Previous research within the Beaumont Infectious Diseases Research Program found an overall increase in antibiotic resistance in adult males versus females. Furthermore, there is a peak in resistance in 18-29-year-old males, not seen in females. The origin of this early peak of antibioti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malamet, Benjamin J, Sims, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776670/ http://dx.doi.org/10.1093/ofid/ofaa439.1537

Ejemplares similares

1355. Global Activity of Imipenem–Relebactam and Comparators Against Clinical Gram-Negative Pathogens – SMART 2017
por: Lob, Sibylle, et al.
Publicado: (2018)

832. Assessment of Risk Factors Associated with Wide-resistance Gram-negative Bacteria Infections
por: Reis, Henry Pablo Lopes Campos e, et al.
Publicado: (2020)

285. Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
por: Chapin, Kimberle, et al.
Publicado: (2020)

1371. Identification of Risk Factors to Predict Gram negative bacteria in Patients with Upper Extremity Infections
por: Zhitomirsky, Sophia, et al.
Publicado: (2021)

647. Adoption of the updated fluoroquinolones breakpoints for Gram negative bacteria in clinical microbiology laboratories
por: Sfeir, Maroun M
Publicado: (2020)

Novel Immunization Strategies Against Multi-drug-resistant Gram-negative Bacteria
por: Youssef, Eman A, et al.
Publicado: (2017)

P1355: DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38-TARGETED LIPID NANOPARTICLES
por: Tarab-Ravski, Dana, et al.
Publicado: (2023)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Transferable resistance in multiresistant Gram-negative bacteria isolated from hemocultures in Slovakia
por: Kulkova, N, et al.
Publicado: (2015)

1355. Efficacy and Tolerability of Linezolid Adjunctive Treatment for Nontuberculous Mycobacterial Infection in Patients with Acquired Anti-Interferon-Gamma Autoantibody
por: Chavapradit, Natthakit, et al.
Publicado: (2019)

1256. In Vivo Activity and Structural Characterization of a New Generation γ-Lactam Siderophore Antibiotic Against Multidrug-Resistant Gram-Negative Bacteria and Acinetobacter spp
por: Goldberg, Joel, et al.
Publicado: (2020)

1278. Testing the Synergistic Effect of Ceftazidime-Avibactam Plus Aztreonam on Metallobetalactamase-Producing Non-Fermenting Gram-negative Bacteria
por: Crouch, Elena M, et al.
Publicado: (2021)

2302. Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Bacteria in Pediatric Intensive Care Unit (PICU): Risk Factors and Outcomes
por: Darda, Violetta-Magdalini, et al.
Publicado: (2018)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

Response of Caenorhabditis elegans during subsequent infections with Gram positive and Gram negative bacteria
por: Mercy, Gnanasekaran Jeba, et al.
Publicado: (2012)

Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period
por: Skiada, A, et al.
Publicado: (2008)

Risk factors for bronchial acquisition of resistant Gram-negative bacteria in critically ill patients and outcome
por: Papakonstantinou, I, et al.
Publicado: (2012)

Factors associated with survival of ICU patients with pneumonia caused by multidrug-resistant Gram-negative bacteria
por: Georgiadou, M, et al.
Publicado: (2015)

1705. Filamentous Hemagglutinin Polyclonal Antibodies Protect against Multidrug resistant Gram-negative bacteria
por: Youssef, Eman, et al.
Publicado: (2022)

Electrical and optical transmission of IEEE 1355 DS-links
por: Haas, S W, et al.
Publicado: (1998)

1608. Efficacy of Ceftolozane/Tazobactam for Multidrug-Resistant Gram-Negative Infections in Multiple Urban Hospitals
por: Cabrera, Nicolo, et al.
Publicado: (2020)

1378. Reservoirs of Transmission of Resistant Gram-negative Pathogens Responsible for Neonatal Sepsis among Hospitalized Neonates in Pune, India
por: Johnson, Julia, et al.
Publicado: (2020)

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

Antimicrobial resistance pattern of gram negative bacteria to 3rd and 4th generation cephalosporins
por: Revathi, P, et al.
Publicado: (2011)

1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe, Latin America, and Asia in 2019
por: Sader, Helio S, et al.
Publicado: (2020)

717. Antimicrobial Resistance of Gram-Negative Bacteria in Respiratory Isolates from an Intensive Care Unit in Guatemala
por: Erdmenger, Diego, et al.
Publicado: (2023)

144. Gram Negative Bacteria with Increased Minimal Inhibitory Concentration for Cefiderocol among Pediatric Patients in a Northern Italy Hospital.
por: Russo, Chiara, et al.
Publicado: (2022)

2475. Incidence of Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Gram-Negative Bacteria in Brazilian Intensive Care Units
por: Souza, Gregory Lauar, et al.
Publicado: (2019)

2521. VE707, a Defined Live Biotherapeutic Product for Prevention of Infection by Multidrug-Resistant Gram-Negative Bacteria
por: Medlock, Gregory, et al.
Publicado: (2023)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

1613. Global 2018 Surveillance of Eravacycline Against Gram-negative Pathogens, Including Multi-drug Resistant Isolates
por: Lijfrock, Virgil, et al.
Publicado: (2020)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

86. Access to Antimicrobial Susceptibility Testing for Novel Gram-Negative Antibiotics
por: Lee, Yuman, et al.
Publicado: (2021)

Challenges in antibiotic resistance: Gram negative bacteria
Publicado: (2020)

644. Phenotypic and Genomic Analysis of Novel, Fastidious, Gram-negative Bacilli Isolated from Clinical Wound Specimens
por: Liu, Benjamin, et al.
Publicado: (2021)

Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
por: Khorshidi, A, et al.
Publicado: (2010)

Four years of experience with carbapenem-resistant Gram-negative bacteria in two tertiary care hospitals in Crete, Greece
por: Tsioutis, C, et al.
Publicado: (2015)

515. Acquisition of Antibiotic-Resistant Gram-Negative Bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trial
por: Harris, Anthony, et al.
Publicado: (2019)

2433. Evaluation of Meropenem (MEM) in Combination With Colistin (COL) Against Colistin-Resistant Extensively Drug-Resistant (XRD) Gram-Negative Bacteria
por: Singh, Nivedita, et al.
Publicado: (2018)

Add-On Therapy with Ertapenem in Infections with Multidrug Resistant Gram-Negative Bacteria: Pediatric Experience
por: Tanır Basaranoglu, Sevgen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7clma3en1qjmosdmm948iqrs5r